US Broker Ratings

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Unveiling a 54% Upside Potential in the Biotech Arena

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is capturing the attention of investors within the biotechnology sector, offering a noteworthy potential upside of 54.26% according to analyst ratings. The company, headquartered in..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A Healthcare Marvel with 25% Upside Potential

Establishment Labs Holdings Inc (NASDAQ: ESTA), a rising star in the healthcare sector, is attracting significant attention from investors. Headquartered in Alajuela, Costa Rica, this medical technology company specializes in..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 67% Potential Upside in the Biotechnology Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the healthcare sector, particularly within the biotechnology industry, is currently capturing investor interest with a potential upside of 67.18%, according to analyst..

The Pennant Group, Inc. (PNTG) Growth Potential: Analysts Forecast a Robust 29.94% Upside

The Pennant Group, Inc. (NASDAQ: PNTG), a prominent player in the healthcare sector, is garnering significant attention from investors as it carves out a niche in the medical care facilities..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 29.59% Potential Upside in Non-Opioid Pain Management Solutions

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the healthcare sector, is gaining attention from investors with its innovative approach to pain management. Specializing in non-opioid solutions, Pacira BioSciences..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Revenue Growth Surges Over 100%, Analysts Eye 9.53% Upside

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is capturing the attention of investors with its remarkable revenue growth and promising analyst ratings. As a key player in the biotechnology sector, this Seattle-based..

UFP Technologies, Inc. (UFPT)

❌ Error generating article: Server error: `POST https://api.openai.com/v1/chat/completions` resulted in a `502 Bad Gateway` response: 502 Bad Gateway 502 Bad Gateway clou (truncated…)

..

agilon health, inc. (AGL) Stock Analysis: Navigating the Challenges in Healthcare with a Unique Platform

agilon health, inc. (NASDAQ: AGL) offers a fascinating glimpse into the evolving landscape of healthcare services, particularly focusing on the needs of seniors through a unique platform that partners with..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 29.77% Potential Upside in Biotechnology

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative approach to tackling metabolic disorders. With a market capitalization of $1.65 billion, this Cambridge, Massachusetts-based..

Integra LifeSciences Holdings C (IART): Investor Outlook with a 17.87% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the medical devices sector, presents an intriguing opportunity for investors navigating the healthcare landscape. With a market capitalization of $1.02..

Evotec SE (EVO) Stock Analysis: Exploring a Potential 47.54% Upside in a Challenging Landscape

Evotec SE (EVO), a notable player in the healthcare sector, specifically in the specialty and generic drug manufacturing industry, operates on a global scale with its headquarters in Hamburg, Germany...

Premier, Inc. (PINC): Investor Outlook Amidst 2.97% Dividend Yield and Zero Buy Ratings

Premier, Inc. (NASDAQ: PINC), a noteworthy player in the healthcare sector, specializes in health information services. With a market capitalization of $2.34 billion, Premier operates as a healthcare improvement company..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 25% Potential Upside with Strong Buy Ratings

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector specializing in medical devices, is capturing the attention of investors with its promising growth prospects and robust market presence...

Kymera Therapeutics (KYMR): Investor Outlook on Biotech’s 59.75% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR), headquartered in Watertown, Massachusetts, is capturing the attention of investors with its promising biotechnology breakthroughs and substantial upside potential. As a clinical-stage biopharmaceutical company, Kymera..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 167% Potential Upside for Investors

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector specializing in diagnostics and pharmaceuticals, is capturing investor attention with a substantial potential upside of 167.54%. With a..

Addus HomeCare Corporation (ADUS) Stock Analysis: A Strong Buy with a 26.56% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS), a key player in the healthcare sector, specifically within the medical care facilities industry, has been capturing investor attention with its substantial growth potential. With..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Potential Upside and Analyst Ratings

Healthcare Services Group, Inc. (NASDAQ: HCSG) has been gaining attention in the healthcare sector, particularly in the medical care facilities industry. Based in Bensalem, Pennsylvania, the company specializes in providing..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 51% Potential Upside

Pulse Biosciences, Inc. (NASDAQ: PLSE), a pioneering company in the healthcare sector, is drawing attention from investors with its cutting-edge innovations in bioelectric medicine. Specializing in medical instruments and supplies,..

MannKind Corporation (MNKD) Stock Analysis: 66.57% Potential Upside Captivates Investors

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, offers a compelling opportunity for investors, bolstered by a promising 66.57% potential upside based on analyst ratings. With a..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Promising 20% Upside in Biotech Innovation

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is currently capturing the attention of investors with its promising pipeline of peptide therapeutics aimed at addressing complex hematology and blood disorders, as well as..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds